Astrana Health (NASDAQ:ASTH) Cut to Strong Sell at Zacks Research

Zacks Research downgraded shares of Astrana Health (NASDAQ:ASTH) from a hold rating to a strong sell rating in a report issued on Monday morning,Zacks.com reports.

ASTH has been the subject of a number of other reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astrana Health in a research note on Wednesday, October 8th. TD Cowen cut their target price on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a research report on Monday. Finally, BTIG Research lowered their price target on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Six analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, Astrana Health presently has a consensus rating of “Hold” and an average target price of $45.29.

Astrana Health Stock Down 1.0%

Shares of NASDAQ:ASTH opened at $23.56 on Monday. The business’s 50 day moving average is $29.94 and its 200 day moving average is $27.75. The stock has a market cap of $1.32 billion, a P/E ratio of 46.20, a price-to-earnings-growth ratio of 0.90 and a beta of 0.79. Astrana Health has a 52-week low of $21.20 and a 52-week high of $45.40. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52.

Astrana Health (NASDAQ:ASTH) last issued its earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The business had revenue of $317.00 million during the quarter. Sell-side analysts predict that Astrana Health will post 1.15 EPS for the current year.

Institutional Trading of Astrana Health

Hedge funds have recently modified their holdings of the company. Amalgamated Bank boosted its holdings in shares of Astrana Health by 3.4% in the 3rd quarter. Amalgamated Bank now owns 12,325 shares of the company’s stock valued at $349,000 after buying an additional 409 shares in the last quarter. Thrivent Financial for Lutherans lifted its position in Astrana Health by 1.5% during the third quarter. Thrivent Financial for Lutherans now owns 30,977 shares of the company’s stock valued at $878,000 after acquiring an additional 455 shares during the last quarter. Principal Financial Group Inc. lifted its position in Astrana Health by 0.3% during the third quarter. Principal Financial Group Inc. now owns 222,985 shares of the company’s stock valued at $6,322,000 after acquiring an additional 611 shares during the last quarter. Savant Capital LLC boosted its stake in Astrana Health by 2.2% in the third quarter. Savant Capital LLC now owns 30,713 shares of the company’s stock valued at $871,000 after acquiring an additional 649 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in Astrana Health by 7.1% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,657 shares of the company’s stock worth $265,000 after purchasing an additional 710 shares during the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.